Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Norwegian biotech law will ban PID (pre-implantation diagnostics):

This article was originally published in Clinica

Executive Summary

The Norwegian government is putting forward proposals for a new biotechnology law that will, among other things, ban pre-implantation diagnostics because it entails "the differentiation of eggs according to specific genetic characteristics". The new law will uphold existing bans on therapeutic cloning and research carried out on fertilised eggs. It will also continue to restrict access to genetic information outside the health service, but will ensure that inherited family diseases are properly documented. In addition, there will be a ban on paternity tests during the embryonic stage, except in rape cases.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT061858

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel